Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 11 | 2021 | 1106 | 1.330 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2021 | 179 | 0.870 |
Why?
|
| Genetic Counseling | 3 | 2018 | 237 | 0.660 |
Why?
|
| Financing, Personal | 1 | 2020 | 14 | 0.630 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 231 | 0.540 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2018 | 52 | 0.540 |
Why?
|
| Students, Medical | 1 | 2021 | 347 | 0.500 |
Why?
|
| Autism Spectrum Disorder | 5 | 2021 | 450 | 0.500 |
Why?
|
| Parents | 5 | 2020 | 1128 | 0.490 |
Why?
|
| Schools, Medical | 2 | 2021 | 113 | 0.480 |
Why?
|
| Genomics | 6 | 2021 | 1621 | 0.480 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2020 | 919 | 0.480 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 464 | 0.440 |
Why?
|
| Quality Improvement | 1 | 2018 | 722 | 0.360 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 82 | 0.360 |
Why?
|
| Genes, Retinoblastoma | 1 | 2011 | 22 | 0.350 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 87 | 0.350 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 78 | 0.340 |
Why?
|
| Genetics | 1 | 2011 | 24 | 0.340 |
Why?
|
| Muscle Weakness | 1 | 2012 | 88 | 0.340 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 179 | 0.340 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 84 | 0.330 |
Why?
|
| Retinoblastoma | 1 | 2011 | 87 | 0.330 |
Why?
|
| Camurati-Engelmann Syndrome | 1 | 2010 | 2 | 0.330 |
Why?
|
| Retinal Neoplasms | 1 | 2011 | 71 | 0.330 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 115 | 0.330 |
Why?
|
| Ovary | 2 | 2016 | 345 | 0.320 |
Why?
|
| Cataract | 1 | 2012 | 153 | 0.320 |
Why?
|
| Bone Diseases, Developmental | 1 | 2010 | 64 | 0.310 |
Why?
|
| Health Educators | 2 | 2020 | 7 | 0.300 |
Why?
|
| Hypopigmentation | 1 | 2009 | 13 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2009 | 48 | 0.290 |
Why?
|
| Puberty, Precocious | 1 | 2009 | 25 | 0.290 |
Why?
|
| Ectodermal Dysplasia | 2 | 2024 | 62 | 0.290 |
Why?
|
| Developmental Disabilities | 3 | 2019 | 781 | 0.280 |
Why?
|
| Aneuploidy | 1 | 2009 | 138 | 0.280 |
Why?
|
| Community Health Workers | 2 | 2020 | 87 | 0.280 |
Why?
|
| Mosaicism | 1 | 2009 | 248 | 0.250 |
Why?
|
| Craniosynostoses | 2 | 2024 | 146 | 0.250 |
Why?
|
| Mutation | 6 | 2024 | 6099 | 0.240 |
Why?
|
| Heterozygote | 2 | 2024 | 737 | 0.200 |
Why?
|
| Curriculum | 3 | 2021 | 798 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 3436 | 0.190 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 157 | 0.180 |
Why?
|
| Humans | 26 | 2024 | 131163 | 0.180 |
Why?
|
| Surveys and Questionnaires | 5 | 2020 | 4066 | 0.170 |
Why?
|
| Proteins | 2 | 2019 | 1006 | 0.170 |
Why?
|
| Needs Assessment | 2 | 2019 | 173 | 0.160 |
Why?
|
| DNA Mutational Analysis | 2 | 2012 | 775 | 0.150 |
Why?
|
| Dynamins | 1 | 2019 | 51 | 0.150 |
Why?
|
| Office Visits | 1 | 2018 | 80 | 0.140 |
Why?
|
| Child | 11 | 2024 | 26341 | 0.130 |
Why?
|
| Health Education | 1 | 2019 | 228 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 464 | 0.130 |
Why?
|
| Education | 1 | 2018 | 112 | 0.130 |
Why?
|
| Female | 17 | 2024 | 70963 | 0.130 |
Why?
|
| Adult | 11 | 2020 | 31282 | 0.130 |
Why?
|
| Sexual Development | 1 | 2016 | 23 | 0.120 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2016 | 33 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2019 | 299 | 0.120 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2016 | 50 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 523 | 0.110 |
Why?
|
| Craniofacial Abnormalities | 2 | 2019 | 251 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1075 | 0.100 |
Why?
|
| Seizures | 1 | 2019 | 890 | 0.100 |
Why?
|
| Child, Preschool | 7 | 2024 | 15110 | 0.100 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 629 | 0.100 |
Why?
|
| Qualitative Research | 2 | 2016 | 730 | 0.090 |
Why?
|
| DNA Polymerase gamma | 1 | 2012 | 19 | 0.090 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 23 | 0.090 |
Why?
|
| Glutarates | 1 | 2012 | 39 | 0.090 |
Why?
|
| Eye Enucleation | 1 | 2011 | 34 | 0.090 |
Why?
|
| Male | 13 | 2024 | 64957 | 0.090 |
Why?
|
| Neoplasms | 2 | 2020 | 3016 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2019 | 910 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 468 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 282 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2011 | 119 | 0.080 |
Why?
|
| Risk Management | 1 | 2011 | 67 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 889 | 0.080 |
Why?
|
| Age of Onset | 1 | 2012 | 592 | 0.080 |
Why?
|
| Osteochondrodysplasias | 1 | 2010 | 68 | 0.080 |
Why?
|
| Syndrome | 2 | 2011 | 1155 | 0.080 |
Why?
|
| Texas | 4 | 2020 | 3686 | 0.070 |
Why?
|
| Phenotype | 2 | 2024 | 4497 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 573 | 0.070 |
Why?
|
| Genome, Human | 1 | 2015 | 1321 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2012 | 564 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 1064 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 743 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1939 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2010 | 210 | 0.070 |
Why?
|
| DNA Repair | 1 | 2011 | 571 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17753 | 0.070 |
Why?
|
| Physicians | 2 | 2011 | 635 | 0.070 |
Why?
|
| Mutation, Missense | 3 | 2019 | 919 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2011 | 562 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 420 | 0.060 |
Why?
|
| Infant | 4 | 2024 | 13352 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2024 | 56 | 0.050 |
Why?
|
| Limb Deformities, Congenital | 1 | 2024 | 118 | 0.050 |
Why?
|
| Young Adult | 2 | 2019 | 10103 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 5196 | 0.040 |
Why?
|
| Pedigree | 2 | 2016 | 1677 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2020 | 107 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 231 | 0.040 |
Why?
|
| Self Efficacy | 1 | 2020 | 211 | 0.040 |
Why?
|
| Exome | 2 | 2015 | 1061 | 0.040 |
Why?
|
| Awareness | 1 | 2019 | 78 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 42 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 197 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 2602 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8635 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 155 | 0.030 |
Why?
|
| Language Development Disorders | 1 | 2019 | 177 | 0.030 |
Why?
|
| Base Sequence | 2 | 2012 | 2730 | 0.030 |
Why?
|
| Decision Making | 2 | 2016 | 726 | 0.030 |
Why?
|
| Neuroglia | 1 | 2019 | 224 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 915 | 0.030 |
Why?
|
| Psychometrics | 1 | 2021 | 678 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2019 | 480 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 401 | 0.030 |
Why?
|
| Sex Determination Processes | 1 | 2016 | 11 | 0.030 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2016 | 25 | 0.030 |
Why?
|
| Karyotype | 1 | 2016 | 30 | 0.030 |
Why?
|
| Gonads | 1 | 2016 | 32 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1445 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2019 | 398 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 61 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 349 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1673 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 789 | 0.030 |
Why?
|
| Testis | 1 | 2016 | 389 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2904 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 718 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 785 | 0.020 |
Why?
|
| United States | 2 | 2019 | 12072 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1089 | 0.020 |
Why?
|
| Epilepsy | 1 | 2019 | 876 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1590 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 201 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 199 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 154 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 258 | 0.020 |
Why?
|
| Genes, BRCA2 | 1 | 2011 | 49 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2011 | 60 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 533 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 151 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2012 | 308 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2011 | 276 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 28601 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 743 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1979 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 566 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 588 | 0.020 |
Why?
|
| DNA Replication | 1 | 2011 | 355 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 726 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2395 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6459 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3175 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3464 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 20987 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 33912 | 0.010 |
Why?
|